Tezepelumab
CAS No. 1572943-04-4
Tezepelumab( —— )
Catalog No. M36866 CAS No. 1572943-04-4
Tezepelumab (AMG 157) is a humanized monoclonal antibody (IgG2λ) targeting TSLP that prevents TSLP from interacting with its heterodimer receptor. Tezepelumab can be used to study advanced asthma disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 1611 | Get Quote |
|
| 5MG | 2204 | Get Quote |
|
| 10MG | 2974 | Get Quote |
|
| 25MG | 4296 | Get Quote |
|
| 50MG | 5778 | Get Quote |
|
| 100MG | 7632 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTezepelumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionTezepelumab (AMG 157) is a humanized monoclonal antibody (IgG2λ) targeting TSLP that prevents TSLP from interacting with its heterodimer receptor. Tezepelumab can be used to study advanced asthma disease.
-
DescriptionTezepelumab (AMG 157) is human monoclonal antibody (IgG2λ) that binds specifically to TSLP, blocking it from interacting with its heterodimeric receptor. Tezepelumab can be used for the research of severe, uncontrolled asthma.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1572943-04-4
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Menzies-Gow A, et, al. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma. N Engl J Med. 2021 May 13;384(19):1800-1809. ?
molnova catalog
related products
-
NES Topoisomerase II...
NES Topoisomerase II alpha (1017 - 1028)
-
UDP-Glucose sodium s...
UDP-Glucose sodium salt is an endogenous nucleotide sugar involved in glycosyltransferase reactions in metabolism. It is an agonist of the P2Y14 receptor (EC50 = 0.35 μM). It can also bind to and activate GPR17 inducing oligodendrocyte differentiation at a maximal concentration of 100 μM.
-
RS domain derived pe...
RS domain derived peptide
Cart
sales@molnova.com